Skip to main content

WELLS FARGO & COMPANY/MN

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 72971 SAN FRANCISCO, CA

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,112,892
+$2,709,973 QoQ
Shares Held
48,677
+481.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. KNSA ranks #22 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,112,892 48,677
2026-03-31 $402,919 8,368
2025-12-31 $2,243,710 54,393
2025-09-30 $297,747 7,668
2025-06-30 $141,586 5,117
2025-03-31 $453,794 20,432
2024-12-31 $417,396 21,102
2024-09-30 $340,837 13,639
2024-06-30 $263,862 14,133